• Cash runway extended into the second half of 2026 • Average sales price per share was over 10% higher than the June 2025 public offering price SHELTON, Conn., Aug. 4, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical...
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025
Seeking Alpha / 17 hours ago 2 Views
Comments